Endometriosis affects a large number of women who are in their reproductive age. It is estimated to have a prevalence rate of 1 in 10 among women in the reproductive age group. The number is rising with the growing population count in that age range. Though there isn?t a complete cure for this condition, effective endometriosis treatment is provided through medication which suppresses the extreme pain suffered during endometriosis. There are many assumptions to be taken in order to estimate the correct prevalence of endometriosis patients. The absolute prevalent population is always limited as most cases in developing regions are not reported. Also, the awareness and understanding of different scales of pain is very limited in most regions. Hence, cases of endometriosis often get ignored. The situation persists in not only developing or poor socio-economic countries, but developed countries like the UK, where it is assumed that around 2 million women have undiagnosed endometriosis. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Endometriosis Treatment Drugs market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyses the impact of Coronavirus COVID-19 on the Endometriosis Treatment Drugs industry. Based on our recent survey, we have several different scenarios about the Endometriosis Treatment Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Endometriosis Treatment Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endometriosis Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endometriosis Treatment Drugs market in terms of both revenue and volume. Players, stakeholders, and other participants in the global Endometriosis Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026. Sales and Pricing Analyses Readers are provided with deeper sales analysis and pricing analysis for the global Endometriosis Treatment Drugs market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026. In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020. Regional and Country-level Analysis The report offers an exhaustive geographical analysis of the global Endometriosis Treatment Drugs market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026. Competition Analysis In the competitive analysis section of the report, leading as well as prominent players of the global Endometriosis Treatment Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endometriosis Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endometriosis Treatment Drugs market. The following manufacturers are covered in this report: AbbVie Inc Bayer AG AstraZeneca Pfizer Inc Teva Pharmaceutical Industries Ltd Ipsen Pharma Myovant Sciences Ltd Endoceutics, Inc Debiopharm Group Mayne Pharma Group Endometriosis Treatment Drugs Breakdown Data by Type Oral Type Others Endometriosis Treatment Drugs Breakdown Data by Application Hospital Pharmacies Retail Pharmacies E-Commerce Others
This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Market Estimation
Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.
Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.
1 Study Coverage 1.1 Endometriosis Treatment Drugs Product Introduction 1.2 Market Segments 1.3 Key Endometriosis Treatment Drugs Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Endometriosis Treatment Drugs Market Size Growth Rate by Type 1.4.2 Oral Type 1.4.3 Others 1.5 Market by Application 1.5.1 Global Endometriosis Treatment Drugs Market Size Growth Rate by Application 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 E-Commerce 1.5.5 Others 1.6 Coronavirus Disease 2019 (Covid-19): Endometriosis Treatment Drugs Industry Impact 1.6.1 How the Covid-19 is Affecting the Endometriosis Treatment Drugs Industry 1.6.1.1 Endometriosis Treatment Drugs Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19?s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Endometriosis Treatment Drugs Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Endometriosis Treatment Drugs Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Executive Summary 2.1 Global Endometriosis Treatment Drugs Market Size Estimates and Forecasts 2.1.1 Global Endometriosis Treatment Drugs Revenue 2015-2026 2.1.2 Global Endometriosis Treatment Drugs Sales 2015-2026 2.2 Endometriosis Treatment Drugs Market Size by Region: 2020 Versus 2026 2.2.1 Global Endometriosis Treatment Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Endometriosis Treatment Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Endometriosis Treatment Drugs Competitor Landscape by Players 3.1 Endometriosis Treatment Drugs Sales by Manufacturers 3.1.1 Endometriosis Treatment Drugs Sales by Manufacturers (2015-2020) 3.1.2 Endometriosis Treatment Drugs Sales Market Share by Manufacturers (2015-2020) 3.2 Endometriosis Treatment Drugs Revenue by Manufacturers 3.2.1 Endometriosis Treatment Drugs Revenue by Manufacturers (2015-2020) 3.2.2 Endometriosis Treatment Drugs Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Endometriosis Treatment Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Endometriosis Treatment Drugs Revenue in 2019 3.2.5 Global Endometriosis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Endometriosis Treatment Drugs Price by Manufacturers 3.4 Endometriosis Treatment Drugs Manufacturing Base Distribution, Product Types 3.4.1 Endometriosis Treatment Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Endometriosis Treatment Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Endometriosis Treatment Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Endometriosis Treatment Drugs Market Size by Type (2015-2020) 4.1.1 Global Endometriosis Treatment Drugs Sales by Type (2015-2020) 4.1.2 Global Endometriosis Treatment Drugs Revenue by Type (2015-2020) 4.1.3 Endometriosis Treatment Drugs Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Endometriosis Treatment Drugs Market Size Forecast by Type (2021-2026) 4.2.1 Global Endometriosis Treatment Drugs Sales Forecast by Type (2021-2026) 4.2.2 Global Endometriosis Treatment Drugs Revenue Forecast by Type (2021-2026) 4.2.3 Endometriosis Treatment Drugs Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Endometriosis Treatment Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026) 5.1 Global Endometriosis Treatment Drugs Market Size by Application (2015-2020) 5.1.1 Global Endometriosis Treatment Drugs Sales by Application (2015-2020) 5.1.2 Global Endometriosis Treatment Drugs Revenue by Application (2015-2020) 5.1.3 Endometriosis Treatment Drugs Price by Application (2015-2020) 5.2 Endometriosis Treatment Drugs Market Size Forecast by Application (2021-2026) 5.2.1 Global Endometriosis Treatment Drugs Sales Forecast by Application (2021-2026) 5.2.2 Global Endometriosis Treatment Drugs Revenue Forecast by Application (2021-2026) 5.2.3 Global Endometriosis Treatment Drugs Price Forecast by Application (2021-2026) 6 North America 6.1 North America Endometriosis Treatment Drugs by Country 6.1.1 North America Endometriosis Treatment Drugs Sales by Country 6.1.2 North America Endometriosis Treatment Drugs Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Endometriosis Treatment Drugs Market Facts & Figures by Type 6.3 North America Endometriosis Treatment Drugs Market Facts & Figures by Application 7 Europe 7.1 Europe Endometriosis Treatment Drugs by Country 7.1.1 Europe Endometriosis Treatment Drugs Sales by Country 7.1.2 Europe Endometriosis Treatment Drugs Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Endometriosis Treatment Drugs Market Facts & Figures by Type 7.3 Europe Endometriosis Treatment Drugs Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Endometriosis Treatment Drugs by Region 8.1.1 Asia Pacific Endometriosis Treatment Drugs Sales by Region 8.1.2 Asia Pacific Endometriosis Treatment Drugs Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Endometriosis Treatment Drugs Market Facts & Figures by Type 8.3 Asia Pacific Endometriosis Treatment Drugs Market Facts & Figures by Application 9 Latin America 9.1 Latin America Endometriosis Treatment Drugs by Country 9.1.1 Latin America Endometriosis Treatment Drugs Sales by Country 9.1.2 Latin America Endometriosis Treatment Drugs Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Endometriosis Treatment Drugs Market Facts & Figures by Type 9.3 Central & South America Endometriosis Treatment Drugs Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Endometriosis Treatment Drugs by Country 10.1.1 Middle East and Africa Endometriosis Treatment Drugs Sales by Country 10.1.2 Middle East and Africa Endometriosis Treatment Drugs Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Endometriosis Treatment Drugs Market Facts & Figures by Type 10.3 Middle East and Africa Endometriosis Treatment Drugs Market Facts & Figures by Application 11 Company Profiles 11.1 AbbVie Inc 11.1.1 AbbVie Inc Corporation Information 11.1.2 AbbVie Inc Description, Business Overview and Total Revenue 11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020) 11.1.4 AbbVie Inc Endometriosis Treatment Drugs Products Offered 11.1.5 AbbVie Inc Recent Development 11.2 Bayer AG 11.2.1 Bayer AG Corporation Information 11.2.2 Bayer AG Description, Business Overview and Total Revenue 11.2.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Bayer AG Endometriosis Treatment Drugs Products Offered 11.2.5 Bayer AG Recent Development 11.3 AstraZeneca 11.3.1 AstraZeneca Corporation Information 11.3.2 AstraZeneca Description, Business Overview and Total Revenue 11.3.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020) 11.3.4 AstraZeneca Endometriosis Treatment Drugs Products Offered 11.3.5 AstraZeneca Recent Development 11.4 Pfizer Inc 11.4.1 Pfizer Inc Corporation Information 11.4.2 Pfizer Inc Description, Business Overview and Total Revenue 11.4.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Pfizer Inc Endometriosis Treatment Drugs Products Offered 11.4.5 Pfizer Inc Recent Development 11.5 Teva Pharmaceutical Industries Ltd 11.5.1 Teva Pharmaceutical Industries Ltd Corporation Information 11.5.2 Teva Pharmaceutical Industries Ltd Description, Business Overview and Total Revenue 11.5.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Products Offered 11.5.5 Teva Pharmaceutical Industries Ltd Recent Development 11.6 Ipsen Pharma 11.6.1 Ipsen Pharma Corporation Information 11.6.2 Ipsen Pharma Description, Business Overview and Total Revenue 11.6.3 Ipsen Pharma Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Ipsen Pharma Endometriosis Treatment Drugs Products Offered 11.6.5 Ipsen Pharma Recent Development 11.7 Myovant Sciences Ltd 11.7.1 Myovant Sciences Ltd Corporation Information 11.7.2 Myovant Sciences Ltd Description, Business Overview and Total Revenue 11.7.3 Myovant Sciences Ltd Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Myovant Sciences Ltd Endometriosis Treatment Drugs Products Offered 11.7.5 Myovant Sciences Ltd Recent Development 11.8 Endoceutics, Inc 11.8.1 Endoceutics, Inc Corporation Information 11.8.2 Endoceutics, Inc Description, Business Overview and Total Revenue 11.8.3 Endoceutics, Inc Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Endoceutics, Inc Endometriosis Treatment Drugs Products Offered 11.8.5 Endoceutics, Inc Recent Development 11.9 Debiopharm Group 11.9.1 Debiopharm Group Corporation Information 11.9.2 Debiopharm Group Description, Business Overview and Total Revenue 11.9.3 Debiopharm Group Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Debiopharm Group Endometriosis Treatment Drugs Products Offered 11.9.5 Debiopharm Group Recent Development 11.10 Mayne Pharma Group 11.10.1 Mayne Pharma Group Corporation Information 11.10.2 Mayne Pharma Group Description, Business Overview and Total Revenue 11.10.3 Mayne Pharma Group Sales, Revenue and Gross Margin (2015-2020) 11.10.4 Mayne Pharma Group Endometriosis Treatment Drugs Products Offered 11.10.5 Mayne Pharma Group Recent Development 11.1 AbbVie Inc 11.1.1 AbbVie Inc Corporation Information 11.1.2 AbbVie Inc Description, Business Overview and Total Revenue 11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020) 11.1.4 AbbVie Inc Endometriosis Treatment Drugs Products Offered 11.1.5 AbbVie Inc Recent Development 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Endometriosis Treatment Drugs Market Estimates and Projections by Region 12.1.1 Global Endometriosis Treatment Drugs Sales Forecast by Regions 2021-2026 12.1.2 Global Endometriosis Treatment Drugs Revenue Forecast by Regions 2021-2026 12.2 North America Endometriosis Treatment Drugs Market Size Forecast (2021-2026) 12.2.1 North America: Endometriosis Treatment Drugs Sales Forecast (2021-2026) 12.2.2 North America: Endometriosis Treatment Drugs Revenue Forecast (2021-2026) 12.2.3 North America: Endometriosis Treatment Drugs Market Size Forecast by Country (2021-2026) 12.3 Europe Endometriosis Treatment Drugs Market Size Forecast (2021-2026) 12.3.1 Europe: Endometriosis Treatment Drugs Sales Forecast (2021-2026) 12.3.2 Europe: Endometriosis Treatment Drugs Revenue Forecast (2021-2026) 12.3.3 Europe: Endometriosis Treatment Drugs Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Endometriosis Treatment Drugs Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Endometriosis Treatment Drugs Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Endometriosis Treatment Drugs Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Endometriosis Treatment Drugs Market Size Forecast by Region (2021-2026) 12.5 Latin America Endometriosis Treatment Drugs Market Size Forecast (2021-2026) 12.5.1 Latin America: Endometriosis Treatment Drugs Sales Forecast (2021-2026) 12.5.2 Latin America: Endometriosis Treatment Drugs Revenue Forecast (2021-2026) 12.5.3 Latin America: Endometriosis Treatment Drugs Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Endometriosis Treatment Drugs Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Endometriosis Treatment Drugs Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Endometriosis Treatment Drugs Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Endometriosis Treatment Drugs Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter?s Five Forces Analysis 13.5 Primary Interviews with Key Endometriosis Treatment Drugs Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Endometriosis Treatment Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details
